Literature DB >> 17729409

Prognostic value of (13)C-phenylalanine breath test on predicting survival in patients with chronic liver failure.

I Gallardo-Wong1, S Morán, G Rodríguez-Leal, B Castañeda-Romero, R Mera, J Poo, M Uribe, M Dehesa.   

Abstract

AIM: To evaluate the prognostic value of percentage of (13)C-phenylalanine oxidation ((13)C-PheOx) obtained by (13)C-phenylalanine breath test ((13)C-PheBT) on the survival of patients with chronic liver failure.
METHODS: The hepatic function was determined by standard liver blood tests and the percentage of (13)C-PheOx in 118 chronic liver failure patients. The follow-up period was of 64 mo. Survival analysis was performed by the Kaplan-Meier method and variables that were significant (P < 0.10) in univariate analysis and subsequently introduced in a multivariate analysis according to the hazard model proposed by Cox.
RESULTS: Forty-one patients died due to progressive liver failure during the follow-up period. The probability of survival at 12, 24, 36, 48 and 64 mo was 0.88, 0.78, 0.66, 0.57 and 0.19, respectively. Multivariate analysis demonstrated that Child-Pugh classes, age, creatinine and the percentage of (13)C-PheOx (HR 0.338, 95% CI: 0.150-0.762, P = 0.009) were independent predictors of survival. When Child-Pugh classes were replaced by all the parameters of the score, only albumin, bilirubin, creatinine, age and the percentage of (13)C-PheOx (HR 0.449, 95% CI: 0.206-0.979, P = 0.034) were found to be independent predictors of survival.
CONCLUSION: Percentage of (13)C-PheOx obtained by (13)C-PheBT is a strong predictor of survival in patients with chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17729409      PMCID: PMC4611830          DOI: 10.3748/wjg.v13.i34.4579

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  Validation of 13CO2 breath analysis as a measurement of demethylation of stable isotope labeled aminopyrine in man.

Authors:  J F Schneider; D A Schoeller; B Nemchausky; J L Boyer; P Klein
Journal:  Clin Chim Acta       Date:  1978-03-01       Impact factor: 3.786

2.  Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis.

Authors:  I Albers; H Hartmann; J Bircher; W Creutzfeldt
Journal:  Scand J Gastroenterol       Date:  1989-04       Impact factor: 2.423

3.  Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels.

Authors:  D Festi; S Capodicasa; L Sandri; L Colaiocco-Ferrante; T Staniscia; E Vitacolonna; A Vestito; P Simoni; G Mazzella; P Portincasa; E Roda; A Colecchia
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

Review 4.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

5.  Evaluation of 13C-phenylalanine and 13C-tyrosine breath tests for the measurement of hepatocyte functional capacity in patients with liver cirrhosis.

Authors:  T Ishii; M Furube; S Hirano; K Takatori; K Iida; M Kajiwara
Journal:  Chem Pharm Bull (Tokyo)       Date:  2001-12       Impact factor: 1.645

6.  Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics.

Authors:  C Infante-Rivard; S Esnaola; J P Villeneuve
Journal:  Hepatology       Date:  1987 Jul-Aug       Impact factor: 17.425

7.  Patients with severe liver cirrhosis followed up by L-[1-(13)C] phenylalanine breath test.

Authors:  Yukimoto Ishii; Shigeru Suzuki; Tomohisa Kohno; Masaru Aoki; Iori Goto; Tadashi Kohno; Asuka Ito; Satoshi Asai
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

8.  Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease.

Authors:  Adnan Said; John Williams; Jeremy Holden; Patrick Remington; Ronald Gangnon; Alexandru Musat; Michael R Lucey
Journal:  J Hepatol       Date:  2004-06       Impact factor: 25.083

9.  Prognostic value of the aminopyrine breath test in cirrhotic patients.

Authors:  J P Villeneuve; C Infante-Rivard; M Ampelas; G Pomier-Layrargues; P M Huet; D Marleau
Journal:  Hepatology       Date:  1986 Sep-Oct       Impact factor: 17.425

10.  Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease.

Authors:  J F Schneider; A L Baker; N W Haines; G Hatfield; J L Boyer
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

View more
  2 in total

1.  Clinical research on liver reserve function by 13C-phenylalanine breath test in aged patients with chronic liver diseases.

Authors:  Gan-sheng Zhang; Zhi-jun Bao; Jian Zou; Shu-ming Yin; Yi-qin Huang; Hai Huang; De-kai Qiu
Journal:  BMC Geriatr       Date:  2010-05-12       Impact factor: 3.921

Review 2.  (13)CO2 breath tests in non-invasive hepatological diagnosis.

Authors:  Joanna Musialik; Krzysztof Jonderko; Anna Kasicka-Jonderko; Magdalena Buschhaus
Journal:  Prz Gastroenterol       Date:  2015-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.